Risk factors for gastrointestinal perforation and anastomotic leak in patients submitted to cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)
Background: Gastrointestinal leak is one of the most feared complications after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS-HIPEC) and harbors significant postoperative morbidity and mortality. We aim to identify risk-factors for anastomotic leak (AL) and gastrointestin...
| Główni autorzy: | , , , , , |
|---|---|
| Format: | Artykuł |
| Wydane: |
Elsevier
2023
|
| _version_ | 1825939706597081088 |
|---|---|
| author | Nogueiro, Jorge Nik Qisti Fathi Guaglio, Marcello Baratti, Dario Kusamura, Shigeki Deraco, Marcello |
| author_facet | Nogueiro, Jorge Nik Qisti Fathi Guaglio, Marcello Baratti, Dario Kusamura, Shigeki Deraco, Marcello |
| author_sort | Nogueiro, Jorge |
| collection | UPM |
| description | Background: Gastrointestinal leak is one of the most feared complications after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS-HIPEC) and harbors significant postoperative morbidity and mortality. We aim to identify risk-factors for anastomotic leak (AL) and gastrointestinal perforation (GP) to optimize postoperative outcomes of this population.
Methods: We performed a retrospective analysis of 1043 consecutive patients submitted to CRS in a single institution. Potential risk factors for AL and GP, both related to patient overall condition, disease status and surgical technique were reviewed.
Results: Anastomotic leaks were identified in 5.2% of patients, and GPs in 7.0%. The independent risk-factors for AL were age at surgery (OR1.40; CI95% 1.10–1.79); peritoneal cancer index (PCI) (OR1.04, CI95% 1.01–1.07); Cisplatin dose >240 mg during HIPEC (OR3.53; CI95% 1.47–8.56) and the presence of colorectal (CR) or colo-colic (CC) anastomosis (OR5.09; CI95% 2.71–9.53, and 4.58; CI95% 1.22–17.24 respectively). Male gender and intraoperative red blood cell transfusions were the only independent risk factors for GP identified (OR1.70; CI95% 1.04–2.78 and 1.06; CI95% 1.01–1.12, respectively). Regarding 30-day and 90-day postoperative mortality, independent risk-factors were mainly related to patient's overall condition.
Conclusion: Gastrointestinal leaks are a frequent source of postoperative morbidity, mainly at the expense of GP. A careful and systematic intraoperative revision of all potential gastrointestinal injuries is equally critical to perfecting anastomotic fashioning techniques to decrease gastrointestinal complication rates. We identified multiple risk-factors for AL and GP related to disease status and patient condition. Our study suggests that patient-related conditions are of paramount relevance, highlighting the importance of patient selection and preoperative patient optimization. |
| first_indexed | 2024-12-09T02:21:18Z |
| format | Article |
| id | upm.eprints-109071 |
| institution | Universiti Putra Malaysia |
| last_indexed | 2024-12-09T02:21:18Z |
| publishDate | 2023 |
| publisher | Elsevier |
| record_format | dspace |
| spelling | upm.eprints-1090712024-10-15T05:31:17Z http://psasir.upm.edu.my/id/eprint/109071/ Risk factors for gastrointestinal perforation and anastomotic leak in patients submitted to cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) Nogueiro, Jorge Nik Qisti Fathi Guaglio, Marcello Baratti, Dario Kusamura, Shigeki Deraco, Marcello Background: Gastrointestinal leak is one of the most feared complications after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS-HIPEC) and harbors significant postoperative morbidity and mortality. We aim to identify risk-factors for anastomotic leak (AL) and gastrointestinal perforation (GP) to optimize postoperative outcomes of this population. Methods: We performed a retrospective analysis of 1043 consecutive patients submitted to CRS in a single institution. Potential risk factors for AL and GP, both related to patient overall condition, disease status and surgical technique were reviewed. Results: Anastomotic leaks were identified in 5.2% of patients, and GPs in 7.0%. The independent risk-factors for AL were age at surgery (OR1.40; CI95% 1.10–1.79); peritoneal cancer index (PCI) (OR1.04, CI95% 1.01–1.07); Cisplatin dose >240 mg during HIPEC (OR3.53; CI95% 1.47–8.56) and the presence of colorectal (CR) or colo-colic (CC) anastomosis (OR5.09; CI95% 2.71–9.53, and 4.58; CI95% 1.22–17.24 respectively). Male gender and intraoperative red blood cell transfusions were the only independent risk factors for GP identified (OR1.70; CI95% 1.04–2.78 and 1.06; CI95% 1.01–1.12, respectively). Regarding 30-day and 90-day postoperative mortality, independent risk-factors were mainly related to patient's overall condition. Conclusion: Gastrointestinal leaks are a frequent source of postoperative morbidity, mainly at the expense of GP. A careful and systematic intraoperative revision of all potential gastrointestinal injuries is equally critical to perfecting anastomotic fashioning techniques to decrease gastrointestinal complication rates. We identified multiple risk-factors for AL and GP related to disease status and patient condition. Our study suggests that patient-related conditions are of paramount relevance, highlighting the importance of patient selection and preoperative patient optimization. Elsevier 2023-10 Article PeerReviewed Nogueiro, Jorge and Nik Qisti Fathi and Guaglio, Marcello and Baratti, Dario and Kusamura, Shigeki and Deraco, Marcello (2023) Risk factors for gastrointestinal perforation and anastomotic leak in patients submitted to cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). European Journal of Surgical Oncology, 49 (10). art. no. 107020. pp. 1-7. ISSN 0748-7983; ESSN: 1532-2157 https://linkinghub.elsevier.com/retrieve/pii/S0748798323006583 10.1016/j.ejso.2023.107020 |
| spellingShingle | Nogueiro, Jorge Nik Qisti Fathi Guaglio, Marcello Baratti, Dario Kusamura, Shigeki Deraco, Marcello Risk factors for gastrointestinal perforation and anastomotic leak in patients submitted to cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) |
| title | Risk factors for gastrointestinal perforation and anastomotic leak in patients submitted to cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) |
| title_full | Risk factors for gastrointestinal perforation and anastomotic leak in patients submitted to cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) |
| title_fullStr | Risk factors for gastrointestinal perforation and anastomotic leak in patients submitted to cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) |
| title_full_unstemmed | Risk factors for gastrointestinal perforation and anastomotic leak in patients submitted to cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) |
| title_short | Risk factors for gastrointestinal perforation and anastomotic leak in patients submitted to cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) |
| title_sort | risk factors for gastrointestinal perforation and anastomotic leak in patients submitted to cytoreductive surgery crs and hyperthermic intraperitoneal chemotherapy hipec |
| work_keys_str_mv | AT nogueirojorge riskfactorsforgastrointestinalperforationandanastomoticleakinpatientssubmittedtocytoreductivesurgerycrsandhyperthermicintraperitonealchemotherapyhipec AT nikqistifathi riskfactorsforgastrointestinalperforationandanastomoticleakinpatientssubmittedtocytoreductivesurgerycrsandhyperthermicintraperitonealchemotherapyhipec AT guagliomarcello riskfactorsforgastrointestinalperforationandanastomoticleakinpatientssubmittedtocytoreductivesurgerycrsandhyperthermicintraperitonealchemotherapyhipec AT barattidario riskfactorsforgastrointestinalperforationandanastomoticleakinpatientssubmittedtocytoreductivesurgerycrsandhyperthermicintraperitonealchemotherapyhipec AT kusamurashigeki riskfactorsforgastrointestinalperforationandanastomoticleakinpatientssubmittedtocytoreductivesurgerycrsandhyperthermicintraperitonealchemotherapyhipec AT deracomarcello riskfactorsforgastrointestinalperforationandanastomoticleakinpatientssubmittedtocytoreductivesurgerycrsandhyperthermicintraperitonealchemotherapyhipec |